Daniel Faga
Director, President, CEO · 5 filings · Latest: May 12, 2026
ANAPTYSBIO, INC
First Tracks Biotherapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ANAB | Daniel Faga | Director, President, CEO | Mar 27, 2026 | Sale | $61.61 | 17,679 | $1.1M | 495,965 | |
ANAB | Daniel Faga | — | Jan 8, 2026 | Proposed Sale | $45.21 | 14,281 | $645.6K | — | |
ANAB | Daniel Faga | — | Jan 7, 2026 | Proposed Sale | $43.91 | 9,202 | $404.1K | — | |
ANAB | Daniel Faga | — | Jan 5, 2026 | Proposed Sale | $44.95 | 15,309 | $688.1K | — |